📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: ViroPharma

1.1 - Company Overview

ViroPharma Logo

ViroPharma

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biopharmaceutical products addressing serious diseases, focused on therapies used by physician specialists or in hospital settings; develops and commercializes treatments, with two marketed products and three development programs, including Vancocin HCl capsules.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to ViroPharma

Biosplice Logo

Biosplice

HQ: United States Website
  • Description: Provider of therapeutic solutions and clinical trials for tissue-level regeneration, developing therapies that modulate alternative splicing via CLK/DYRK kinase inhibition to treat diseases like osteoarthritis and cancer. Offerings include Lorecivivint, an injectable small molecule for knee osteoarthritis to reduce pain, improve function, and protect cartilage, with trials evaluating safety, efficacy, and dosing.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Biosplice company profile →
Oxford Biomedica Logo

Oxford Biomedica

HQ: United Kingdom Website
  • Description: Provider of gene and cell therapy solutions, offering lentiviral LentiVector and AAV platforms for development and manufacturing of gene therapies, plus CDMO services for viral vectors including tech transferred-in execution of client-defined methods, process development, GMP manufacturing, and regulatory support.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Oxford Biomedica company profile →
Lanthiopharma Logo

Lanthiopharma

HQ: The Netherlands Website
  • Description: Provider of drug discovery focused on therapeutic lantipeptide drugs for serious diseases, applying proprietary lanthionine-peptide technology (LanthioPepTM) to generate novel peptide therapeutics with increased resistance to peptidase degradation, high receptor specificity and increased intrinsic activity.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Lanthiopharma company profile →
Mavu Pharma Logo

Mavu Pharma

HQ: United States Website
  • Description: Provider of non-nucleotide, conditional modulators of the STING pathway to treat cancer and infectious disease.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Mavu Pharma company profile →
Altor BioScience Logo

Altor BioScience

HQ: United States Website
  • Description: Provider of immunotherapeutic agents for cancer, viral infections, and autoimmune diseases, including ANKTIVA (N‑803), an IL‑15 receptor agonist for non‑muscle invasive bladder cancer; investigational cancer and viral therapies and vaccines (personalized neoepitope-based, HIV, HPV); Tri‑Ad5 vaccine for Lynch syndrome; STAR Fusion reagents for diagnosis/targeting, STAR Multimer reagents for research; and clinical trials.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Altor BioScience company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for ViroPharma

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to ViroPharma

2.2 - Growth funds investing in similar companies to ViroPharma

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for ViroPharma

4.2 - Public trading comparable groups for ViroPharma

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to ViroPharma

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About ViroPharma

What does ViroPharma do?

ViroPharma is a provider of biopharmaceutical products addressing serious diseases, focused on therapies used by physician specialists or in hospital settings; develops and commercializes treatments, with two marketed products and three development programs, including Vancocin HCl capsules.

Who are ViroPharma's competitors?

ViroPharma's competitors and similar companies include Biosplice, Oxford Biomedica, Lanthiopharma, Mavu Pharma, and Altor BioScience.

Where is ViroPharma headquartered?

ViroPharma is headquartered in United States.

How many employees does ViroPharma have?

ViroPharma has 1,000 employees 🔒.

When was ViroPharma founded?

ViroPharma was founded in 2010 🔒.

What sector and industry vertical is ViroPharma in?

ViroPharma is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for ViroPharma

Who are the top strategic acquirers in ViroPharma's sector and industry

Top strategic M&A buyers and acquirers in ViroPharma's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for ViroPharma?

Top strategic M&A buyers groups and sectors for ViroPharma include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in ViroPharma's sector and industry vertical

Which are the top PE firms investing in ViroPharma's sector and industry vertical?

Top PE firms investing in ViroPharma's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in ViroPharma's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in ViroPharma's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in ViroPharma's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to ViroPharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in ViroPharma's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for ViroPharma?

The key public trading comparables and valuation benchmarks for ViroPharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for ViroPharma for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for ViroPharma with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in ViroPharma's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for ViroPharma with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in ViroPharma's' sector and industry vertical?

Access recent funding rounds and capital raises in ViroPharma's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for ViroPharma